NO20071880L - Diagnostic Compounds - Google Patents

Diagnostic Compounds

Info

Publication number
NO20071880L
NO20071880L NO20071880A NO20071880A NO20071880L NO 20071880 L NO20071880 L NO 20071880L NO 20071880 A NO20071880 A NO 20071880A NO 20071880 A NO20071880 A NO 20071880A NO 20071880 L NO20071880 L NO 20071880L
Authority
NO
Norway
Prior art keywords
peptide
based compounds
compounds
disease
receptors
Prior art date
Application number
NO20071880A
Other languages
English (en)
Norwegian (no)
Inventor
Magne Solbakken
Alan Cuthbertson
Bente E Arbo
Alexander Gibson
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of NO20071880L publication Critical patent/NO20071880L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20071880A 2004-09-14 2007-04-13 Diagnostic Compounds NO20071880L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
NO20071880L true NO20071880L (no) 2007-06-13

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071880A NO20071880L (no) 2004-09-14 2007-04-13 Diagnostic Compounds

Country Status (23)

Country Link
US (2) US7875701B2 (de)
EP (1) EP1791571B1 (de)
JP (1) JP4949251B2 (de)
KR (1) KR101243016B1 (de)
CN (1) CN101151054B (de)
AT (1) ATE404225T1 (de)
AU (1) AU2005283904B8 (de)
BR (1) BRPI0515175A (de)
CA (1) CA2578470C (de)
DE (1) DE602005008996D1 (de)
DK (1) DK1791571T3 (de)
ES (1) ES2312018T3 (de)
GB (1) GB0420344D0 (de)
IL (1) IL181529A (de)
MX (1) MX2007003019A (de)
NO (1) NO20071880L (de)
NZ (1) NZ553384A (de)
PL (1) PL1791571T3 (de)
PT (1) PT1791571E (de)
RU (1) RU2396272C9 (de)
SI (1) SI1791571T1 (de)
WO (1) WO2006030291A2 (de)
ZA (1) ZA200702700B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
EP1985624A3 (de) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Einschrittiges Verfahren zur Radiofluorierung von biologisch aktiven Verbindungen oder Biomolekülen
CA2663454C (en) * 2006-09-15 2015-04-21 Siemens Medical Solutions Usa, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
WO2008072976A2 (en) * 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
WO2008075966A2 (en) * 2006-12-18 2008-06-26 Ge Healthcare As Synthesis of a radiofluorinated peptide using photolabile protecting groups
EP2114464A2 (de) * 2006-12-28 2009-11-11 GE Healthcare AS Radiofluorinationsverfahren
KR20090119966A (ko) * 2007-03-01 2009-11-23 바이엘 쉐링 파마 악티엔게젤샤프트 진단 영상화제로서의 18ｆ 플루오로-벤조일 표지된 생물학적 활성 화합물, 벤조트리아졸-1-일옥시-벤조일, 2,5-디옥소-피롤리딘-1-일옥시)벤조일 및 트리메틸암모니오-벤조일 전구체
EP2195037A2 (de) * 2007-09-10 2010-06-16 GE Healthcare UK Limited Radiofluorinationsverfahren
JP5399422B2 (ja) * 2008-02-28 2014-01-29 ジーイー・ヘルスケア・リミテッド 市販の安価な化学薬品からのｐｅｇ−６成分の合成
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
WO2011084763A1 (en) 2009-12-21 2011-07-14 Ge Healthcare Limited Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion
GB201013808D0 (en) * 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
CA2819347A1 (en) 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
US9180213B2 (en) 2010-12-09 2015-11-10 Ge Healthcare Limited Radiotracer compositions
BR112013015580A2 (pt) * 2010-12-21 2016-10-04 Ge Healthcare Ltd método de radioestabilização
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2016087653A1 (en) 2014-12-04 2016-06-09 Ge Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
EP1791571A2 (de) 2007-06-06
RU2007108762A (ru) 2008-10-27
PL1791571T3 (pl) 2009-01-30
AU2005283904B8 (en) 2012-02-23
PT1791571E (pt) 2008-11-19
DE602005008996D1 (de) 2008-09-25
RU2396272C2 (ru) 2010-08-10
KR20070053750A (ko) 2007-05-25
AU2005283904A1 (en) 2006-03-23
KR101243016B1 (ko) 2013-03-12
CN101151054A (zh) 2008-03-26
AU2005283904B2 (en) 2012-01-19
SI1791571T1 (sl) 2009-02-28
CN101151054B (zh) 2014-09-24
MX2007003019A (es) 2007-08-07
US20110117016A1 (en) 2011-05-19
US8563600B2 (en) 2013-10-22
IL181529A0 (en) 2007-07-04
GB0420344D0 (en) 2004-10-13
ATE404225T1 (de) 2008-08-15
US20080095701A1 (en) 2008-04-24
CA2578470A1 (en) 2006-03-23
US7875701B2 (en) 2011-01-25
IL181529A (en) 2015-04-30
WO2006030291A3 (en) 2007-06-14
DK1791571T3 (da) 2008-12-08
BRPI0515175A (pt) 2008-07-08
EP1791571B1 (de) 2008-08-13
JP2008516894A (ja) 2008-05-22
CA2578470C (en) 2015-09-01
ZA200702700B (en) 2008-09-25
WO2006030291A2 (en) 2006-03-23
NZ553384A (en) 2011-02-25
ES2312018T3 (es) 2009-02-16
HK1118713A1 (en) 2009-02-20
JP4949251B2 (ja) 2012-06-06
RU2396272C9 (ru) 2010-12-10

Similar Documents

Publication Publication Date Title
EA202091710A1 (ru) Антитела против cd73 и способы их применения
JOP20190248A1 (ar) بروتينات ربط مولد ضد trem2 واستخداماته
BR112022004986A2 (pt) Anticorpos anti-tnfr2 e métodos de uso
JOP20210071A1 (ar) أجسام مضادة مثبّتة trem2
GEAP202215050A (en) Antibodies against signal-regulatory protein alpha and methods of use
CY1109522T1 (el) Παραγοντες απεικονισης με βαση δικυκλικο πεπτιδιο
MA64193B1 (fr) Anticorps bispécifiques se liant aux dll3 et cd3
WO2006078746A3 (en) Method, compositions and classification for tumor diagnostics and treatment
WO2012087928A3 (en) Modulating agonistic tnfr antibodies
JP2013506425A5 (de)
EP2805970A3 (de) Antikörper gegen GDF8 und ihre Verwendung
PH12015500113A1 (en) Anti-kit antibodies and uses thereof
Vallet et al. Myeloma bone disease: update on pathogenesis and novel treatment strategies
MX2025000940A (es) Anticuerpos especificos para el transcrito similar a la inmunoglobulina tipo 3 (ilt3) y sus usos
WO2020136145A3 (en) Leucocyte immunoglobulin-like receptor 2 neutralizing antibodies
WO2015200883A3 (en) Semi-synthetic nurse shark vnar libraries for making and using selective binding compounds
JP2018531624A5 (de)
MY202395A (en) Gremlin-1 crystal structure and inhibitory antibody
MX2019012419A (es) Uso de antagonistas de klk5 para el tratamiento de una enfermedad.
EP4345168A3 (de) Verfahren zur herstellung von dna-referenzmaterial und kontrollen
WO2019028182A3 (en) TREATMENT OF CANCER USING ANTIBODIES BINDING TO THE HUMAN CD134 RECEPTOR (OX40)
Matveeva et al. Initiated pseudo-[3+ 2] cycloaddition of mixed phosphonium-iodonium ylides to acetonitrile
MX2019004862A (es) Anticuerpos anti-rankl y usos de los mismos.
MX2009006028A (es) Compuestos basados en peptido radiomarcado y usos de los mismos.
Moser et al. Accessory head of the biceps tendon versus aponeurotic expansion of the supraspinatus tendon

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA